Robust and comparable immunogenicity was observed between adolescents and young adults who received 2- or 3-dose schedules of ...

However, the biologic variability and immunogenicity limit its utility. With increasing volumes of vascular intervention and an aging population, an increase in the need for anticoagulation can be ...